Goldman Sachs Group Inc Agios Pharmaceuticals, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 476,657 shares of AGIO stock, worth $16.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
476,657
Previous 549,003 13.18%
Holding current value
$16.4 Million
Previous $23.7 Million 10.54%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$41.19 - $49.72 $2.98 Million - $3.6 Million
-72,346 Reduced 13.18%
476,657 $21.2 Million
Q2 2024

Aug 13, 2024
BUY
$27.55 - $48.83 $259,548 - $460,027
9,421 Added 1.75%
549,003 $23.7 Million
Q1 2024

May 15, 2024
SELL
$21.32 - $34.81 $1.46 Million - $2.38 Million
-68,356 Reduced 11.24%
539,582 $15.8 Million
Q4 2023

Feb 13, 2024
SELL
$19.97 - $24.53 $3.94 Million - $4.84 Million
-197,499 Reduced 24.52%
607,938 $13.5 Million
Q3 2023

May 14, 2024
BUY
$24.36 - $28.18 $4.81 Million - $5.57 Million
197,499 Added 32.49%
805,437 $19.9 Million
Q3 2023

Nov 14, 2023
BUY
$24.36 - $28.18 $141,897 - $164,148
5,825 Added 0.73%
805,437 $19.9 Million
Q2 2023

May 14, 2024
SELL
$21.38 - $29.19 $3.52 Million - $4.8 Million
-164,550 Reduced 17.07%
799,612 $22.6 Million
Q2 2023

Aug 14, 2023
SELL
$21.38 - $29.19 $3.52 Million - $4.8 Million
-164,550 Reduced 17.07%
799,612 $22.6 Million
Q1 2023

May 14, 2024
SELL
$21.74 - $30.93 $13 Million - $18.5 Million
-598,870 Reduced 38.31%
964,162 $22.1 Million
Q1 2023

May 11, 2023
SELL
$21.74 - $30.93 $13 Million - $18.5 Million
-598,870 Reduced 38.31%
964,162 $22.1 Million
Q4 2022

May 14, 2024
SELL
$24.81 - $31.52 $4.89 Million - $6.21 Million
-197,173 Reduced 11.2%
1,563,032 $43.9 Million
Q4 2022

Feb 13, 2023
SELL
$24.81 - $31.52 $4.89 Million - $6.21 Million
-197,173 Reduced 11.2%
1,563,032 $43.9 Million
Q3 2022

May 14, 2024
BUY
$19.51 - $34.14 $1.67 Million - $2.92 Million
85,392 Added 5.1%
1,760,205 $49.8 Million
Q3 2022

Nov 10, 2022
BUY
$19.51 - $34.14 $1.67 Million - $2.92 Million
85,392 Added 5.1%
1,760,205 $49.8 Million
Q2 2022

May 14, 2024
BUY
$17.06 - $31.42 $18.2 Million - $33.5 Million
1,066,875 Added 175.49%
1,674,813 $37.1 Million
Q2 2022

Aug 15, 2022
SELL
$17.06 - $31.42 $2.43 Million - $4.47 Million
-142,388 Reduced 7.84%
1,674,813 $37.1 Million
Q1 2022

May 16, 2022
SELL
$26.68 - $34.81 $1.7 Million - $2.22 Million
-63,730 Reduced 3.39%
1,817,201 $52.9 Million
Q4 2021

Feb 14, 2022
BUY
$29.58 - $49.78 $2.45 Million - $4.12 Million
82,832 Added 4.61%
1,880,931 $61.8 Million
Q3 2021

Nov 10, 2021
BUY
$41.92 - $58.18 $75.4 Million - $105 Million
1,798,099 New
1,798,099 $83 Million

Others Institutions Holding AGIO

# of Institutions
232
Shares Held
58.1M
Call Options Held
403K
Put Options Held
469K
View Full List

About AGIOS PHARMACEUTICALS, INC.

AGIO Quotes by TradingView
  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $1.89B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email